Kewaunee Scientific Corporation · NASDAQ:KEQU
Kewaunee Scientific — Shareholder Meeting (August 2026)
17 slides from Kewaunee Scientific's shareholder meeting presentation, Aug 26, 2026
Slide 1: Kewaunee Scientific Corporation
KEWAUNEE SCIENTIFIC CORPORATION NASDAQ: KEQU
Slide 2: Special Note Regarding Forward-Looking Statements
Special Note Regarding Forward-Looking Statements Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements other than statements of historical fact included in this presen
Slide 3: About Non-GAAP Measures
The following slides include non-GAAP financial measures such as EBITDA. EBITDA is calculated as net earnings (loss), less interest expense and interest income, income taxes, depreciation, and amortization. We believe EBITDA allows management and investors to compare our performance to other compani
Slide 4: Agenda 2026 Annual Shareholder Meeting
4 Agenda 2026 Annual Shareholder Meeting ❑ Fiscal Year 2026 Review ❑ Investing in the Business ❑ Strategic Direction & Outlook ❑ Q&A
Slide 5: Transformational Growth & Profitability Expansion
Transformational Growth & Profitability Expansion 5 Scaled Platform Three market-leading brands delivering Innovative solutions across the lab lifecycle. Strong Financial Performance Consistent revenue growth & EBITDA expansion over the past five years. Operational Excellence Executing with discipli
Slide 6: Historical Financials
6 Historical Financials Kewaunee Scientific Corporation | NASDAQ: KEQU $203.8M $240.5M $282.0M $155.6M $214.6M $165.9M FY2024 FY2025 FY2026 Revenue Backlog Consolidated Revenue & Backlog FY2026 Key Results ▪ Revenue: $282.0M, extending the Company’s multiyear growth trajectory ▪ EBITDA: $22.4M, refl
Slide 7: Segment Performance: Revenue, EBITDA & Backlog by Segment
Segment Performance: Revenue, EBITDA & Backlog by Segment Stable Annual Revenue Globally $137.3M $179.4M $214.9M $66.5M $61.1M $67.1M FY2024 FY2025 FY2026 LPG International ▪ Renamed Domestic segment as the Lab Products Group to better reflect the org's structure, strategy, and business activities.
Slide 8: Introducing Kewaunee's Lab Products Group
Introducing Kewaunee’s Lab Products Group Guiding Principles ▪ We make it easy to do business with us ▪ We get closer to our customers ▪ We operate with excellence ▪ We lead and earn the right to innovate Core Values ▪ Associates, our foundation ▪ Safety & quality in everything ▪ Customer Focused ▪
Slide 9: Industry-Leading Capabilities: Setting the Standard in Laboratory Solutions
I N D U S T R Y - L E A D I N G C A P A B I L I T I E S Setting the Standard in Laboratory Solutions Robust American Manufacturing The only U.S. manufacturer producing wood, metal, and epoxy resin laboratory furniture at a single location. Extensive Manufacturing Network Six manufacturing facilities
Slide 10: Investing in Our International Growth
Investing in Our International Growth International growth remains an important part of our strategy. To support our next phase of international expansion, we welcomed two new leaders to the Lab Products Group. Together, Jorge and Lucia strengthen our ability to connect global commercial opportuniti
Slide 11: International Turnkey Services
Providing a one-stop solution for laboratory, design, and construction projects for customers in India and the surrounding markets. Design, Build, and Engineering ❑ Engineering, procurement, construction, and real-time project management services ❑ HVAC, exhaust, gas distribution, electrical, fire p
Slide 12: Building a Scalable Corporate Platform
Building a Scalable Corporate Platform CONTROLS & READINESS ▪ SOX 404(b) readiness ▪ Corporate consolidation platform FINANCIAL CAPABILITY ▪ Accounting capabilities ▪ Growth-function resources GOVERNANCE & COMPLIANCE ▪ Bylaw and expenditure- policy updates ▪ Expanded compliance training GLOBAL INVES
Slide 13: Strategic Direction and Outlook
We will do everything with excellence. We will be easy to do business with. OUR GUIDING PRINCIPLES Strategic Direction and Outlook 13 We will get closer to our customer(s). We will lead and not follow (we are innovators). 01 02 03 04
Slide 14: Kewaunee as a Succession Solution
14 Legacy matters at Kewaunee. With 120 years of continuous operation, we’ve built a reputation on trust, reliability, and lasting relationships. As a publicly traded company with strong governance and a disciplined operating approach, we offer a stable platform for companies seeking thoughtful succ
Slide 15: What Sets Us Apart
W H A T S E T S U S A P A R T KEWAUNEE SCIENTIFIC CORPORATION Delivering trusted laboratory environments since 1906. 01 Experience Serving Users in Multiple End-Use Markets The industries served by Kewaunee continue to invest in research and development, requiring Kewaunee products in diverse market
Slide 16: Thank You & Questions
Thank You & Questions 16
Slide 17: Slide 17
Kewaunee Scientific — Shareholder Meeting (August 2026) on 6ix